A breast cancer patient with pelvic and gastric malignancy after adjuvant tamoxifen treatment for breast cancer


Dede M., Gezginç K., Ulubay M., ALANBAY İ., Güran Ş., Yenen M.

European Journal of Gynaecological Oncology, vol.29, no.2, pp.200, 2008 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 29 Issue: 2
  • Publication Date: 2008
  • Journal Name: European Journal of Gynaecological Oncology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.200
  • Keywords: breast cancer, tamoxifen treatment, gastric and pelvic malignancy
  • Lokman Hekim University Affiliated: Yes

Abstract

As is known, tamoxifen therapy is related to endometrial proliferation, hyperplasia, polyp formation, invasive carcinoma and uterine sarcoma. In this study, we present a 75-year-old woman who had five children. Gastric tumor, endometrial carcinoma and cervical adenocarcinoma in situ were detected after treatment with tamoxifen for breast cancer. It seems that being aware of the undersirable affects of tamoxifen treatment during the chemotherapy and post-chemotherapy period is very important.